Wong, T. Y., Ishibashi, T., Ohno-Matsui, K., Ikuno, Y., Korobelnik, J.-F., Stemper, B., … Zeitz, O. (2014). Efficacy and Safety of Intravitreal Aflibercept for Choroidal Neovascularization Secondary to Pathological Myopia: 48-week Results of MYRROR Study. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (Vol. 55). ASSOC RESEARCH VISION OPHTHALMOLOGY INC.

Wong, Tien Y., Tatsuro Ishibashi, Kyoko Ohno-Matsui, Yasushi Ikuno, Jean-Francois Korobelnik, Brigitte Stemper, Yoshimi Matsuda, Tummy Li, Robert Vitti, and Oliver Zeitz. “Efficacy and Safety of Intravitreal Aflibercept for Choroidal Neovascularization Secondary to Pathological Myopia: 48-week Results of MYRROR Study.” In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 55. ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2014.

Wong TY, Ishibashi T, Ohno-Matsui K, Ikuno Y, Korobelnik J-F, Stemper B, et al. Efficacy and Safety of Intravitreal Aflibercept for Choroidal Neovascularization Secondary to Pathological Myopia: 48-week Results of MYRROR Study. In: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC; 2014.

Wong, Tien Y., et al. “Efficacy and Safety of Intravitreal Aflibercept for Choroidal Neovascularization Secondary to Pathological Myopia: 48-week Results of MYRROR Study.” INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 55, no. 13, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2014.

Wong TY, Ishibashi T, Ohno-Matsui K, Ikuno Y, Korobelnik J-F, Stemper B, Matsuda Y, Li T, Vitti R, Zeitz O. Efficacy and Safety of Intravitreal Aflibercept for Choroidal Neovascularization Secondary to Pathological Myopia: 48-week Results of MYRROR Study. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC; 2014.